- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.2: 19 residues within 4Å:- Chain A: D.433, W.434, W.435, L.437, M.438, I.484, I.487, L.488, L.491, Q.507, G.511, L.514
- Chain D: F.531, V.600, T.603, M.604, T.607, I.611
- Ligands: 01.5
14 PLIP interactions:9 interactions with chain A, 5 interactions with chain D- Hydrophobic interactions: A:L.437, A:M.438, A:I.484, A:I.484, A:I.487, A:L.488, D:F.531, D:V.600, D:T.603, D:T.607, D:I.611
- Hydrogen bonds: A:D.433, A:W.434, A:Q.507
PTY.7: 19 residues within 4Å:- Chain A: F.531, V.600, T.603, M.604, T.607, I.611
- Chain B: D.433, W.434, W.435, L.437, M.438, I.484, I.487, L.488, L.491, Q.507, G.511, L.514
- Ligands: 01.10
14 PLIP interactions:5 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:F.531, A:V.600, A:T.603, A:T.607, A:I.611, B:L.437, B:M.438, B:I.484, B:I.484, B:I.487, B:L.488
- Hydrogen bonds: B:D.433, B:W.434, B:Q.507
PTY.12: 19 residues within 4Å:- Chain B: F.531, V.600, T.603, M.604, T.607, I.611
- Chain C: D.433, W.434, W.435, L.437, M.438, I.484, I.487, L.488, L.491, Q.507, G.511, L.514
- Ligands: 01.15
14 PLIP interactions:9 interactions with chain C, 5 interactions with chain B- Hydrophobic interactions: C:L.437, C:M.438, C:I.484, C:I.484, C:I.487, C:L.488, B:F.531, B:V.600, B:T.603, B:T.607, B:I.611
- Hydrogen bonds: C:D.433, C:W.434, C:Q.507
PTY.17: 19 residues within 4Å:- Chain C: F.531, V.600, T.603, M.604, T.607, I.611
- Chain D: D.433, W.434, W.435, L.437, M.438, I.484, I.487, L.488, L.491, Q.507, G.511, L.514
- Ligands: 01.20
14 PLIP interactions:9 interactions with chain D, 5 interactions with chain C- Hydrophobic interactions: D:L.437, D:M.438, D:I.484, D:I.484, D:I.487, D:L.488, C:F.531, C:V.600, C:T.603, C:T.607, C:I.611
- Hydrogen bonds: D:D.433, D:W.434, D:Q.507
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.3: 10 residues within 4Å:- Chain A: F.440, S.444, L.445, A.448, L.452, E.470, W.472, I.477, L.481, I.484
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.440, A:L.445, A:A.448, A:W.472, A:L.481, A:I.484, A:I.484
POV.8: 10 residues within 4Å:- Chain B: F.440, S.444, L.445, A.448, L.452, E.470, W.472, I.477, L.481, I.484
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:F.440, B:L.445, B:A.448, B:W.472, B:L.481, B:I.484, B:I.484
POV.13: 10 residues within 4Å:- Chain C: F.440, S.444, L.445, A.448, L.452, E.470, W.472, I.477, L.481, I.484
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:F.440, C:L.445, C:A.448, C:W.472, C:L.481, C:I.484, C:I.484
POV.18: 10 residues within 4Å:- Chain D: F.440, S.444, L.445, A.448, L.452, E.470, W.472, I.477, L.481, I.484
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:F.440, D:L.445, D:A.448, D:W.472, D:L.481, D:I.484, D:I.484
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.4: 14 residues within 4Å:- Chain A: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
- Chain D: F.522, C.525, L.526, L.529
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:T.371, A:L.375, A:L.493, A:F.497, A:F.497, D:F.522, D:L.526, D:L.529
- Hydrogen bonds: A:Y.316, A:N.500
Y01.9: 14 residues within 4Å:- Chain A: F.522, C.525, L.526, L.529
- Chain B: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:T.371, B:L.375, B:L.493, B:F.497, B:F.497, A:F.522, A:L.526, A:L.529
- Hydrogen bonds: B:Y.316, B:N.500
Y01.14: 14 residues within 4Å:- Chain B: F.522, C.525, L.526, L.529
- Chain C: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:7 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:T.371, C:L.375, C:L.493, C:F.497, C:F.497, B:F.522, B:L.526, B:L.529
- Hydrogen bonds: C:Y.316, C:N.500
Y01.19: 14 residues within 4Å:- Chain C: F.522, C.525, L.526, L.529
- Chain D: W.315, Y.316, F.364, T.371, L.375, L.493, L.496, F.497, A.499, N.500
10 PLIP interactions:3 interactions with chain C, 7 interactions with chain D- Hydrophobic interactions: C:F.522, C:L.526, C:L.529, D:T.371, D:L.375, D:L.493, D:F.497, D:F.497
- Hydrogen bonds: D:Y.316, D:N.500
- 4 x 01: [(2~{S})-2-[(~{E})-octadec-9-enoyl]oxy-3-oxidanyl-propyl] octadec-9-enoate
01.5: 16 residues within 4Å:- Chain A: L.514, L.521, Y.524, L.528, Q.573, F.576, W.577, V.579
- Chain D: F.599, A.602, T.603, G.606, T.607, V.610, I.611
- Ligands: PTY.2
15 PLIP interactions:11 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:L.514, A:L.521, A:Y.524, A:Y.524, A:Y.524, A:L.528, A:Q.573, A:F.576, A:F.576, A:V.579, D:V.610, D:I.611, D:I.611
- Hydrogen bonds: A:Q.573, D:G.606
01.10: 16 residues within 4Å:- Chain A: F.599, A.602, T.603, G.606, T.607, V.610, I.611
- Chain B: L.514, L.521, Y.524, L.528, Q.573, F.576, W.577, V.579
- Ligands: PTY.7
15 PLIP interactions:4 interactions with chain A, 11 interactions with chain B- Hydrophobic interactions: A:V.610, A:I.611, A:I.611, B:L.514, B:L.521, B:Y.524, B:Y.524, B:Y.524, B:L.528, B:Q.573, B:F.576, B:F.576, B:V.579
- Hydrogen bonds: A:G.606, B:Q.573
01.15: 16 residues within 4Å:- Chain B: F.599, A.602, T.603, G.606, T.607, V.610, I.611
- Chain C: L.514, L.521, Y.524, L.528, Q.573, F.576, W.577, V.579
- Ligands: PTY.12
15 PLIP interactions:4 interactions with chain B, 11 interactions with chain C- Hydrophobic interactions: B:V.610, B:I.611, B:I.611, C:L.514, C:L.521, C:Y.524, C:Y.524, C:Y.524, C:L.528, C:Q.573, C:F.576, C:F.576, C:V.579
- Hydrogen bonds: B:G.606, C:Q.573
01.20: 16 residues within 4Å:- Chain C: F.599, A.602, T.603, G.606, T.607, V.610, I.611
- Chain D: L.514, L.521, Y.524, L.528, Q.573, F.576, W.577, V.579
- Ligands: PTY.17
15 PLIP interactions:11 interactions with chain D, 4 interactions with chain C- Hydrophobic interactions: D:L.514, D:L.521, D:Y.524, D:Y.524, D:Y.524, D:L.528, D:Q.573, D:F.576, D:F.576, D:V.579, C:V.610, C:I.611, C:I.611
- Hydrogen bonds: D:Q.573, C:G.606
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K.C. et al., Structure of human TRPC5 in the low Ca environment. To Be Published
- Release Date
- 2025-07-02
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x 01: [(2~{S})-2-[(~{E})-octadec-9-enoyl]oxy-3-oxidanyl-propyl] octadec-9-enoate
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, K.C. et al., Structure of human TRPC5 in the low Ca environment. To Be Published
- Release Date
- 2025-07-02
- Peptides
- Short transient receptor potential channel 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.